Aprepitant recalls
Aprepitant products have been recalled 2 times, most recently on 15 Jun 2022. The recalling company is usually Glenmark Pharmaceuticals Inc., U. The most common reason is manufacturing (cgmp) deviations.
Total recalls2since 2018
Last 12 months0reported
Class I00% of total
Ongoing0latest 15 Jun 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 50%Class III 1 50%
Why aprepitant is recalled
Companies
By year
All aprepitant recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Aprepitant Capsule, USP, 40 mg per unit dose package recalledAprepitant | Mckesson Medical-Surgical Inc. Corporate Office | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS III | Aprepitant Capsules, USP 40 mg Unit recalled by Glenmark PharmaceuticalsAprepitant | Glenmark Pharmaceuticals Inc., U | Packaging Defects | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.